A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Public ClinicalTrials.gov record NCT02178956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Clinical Trial of BBI608 Plus Weekly Paclitaxel vs. Placebo Plus Weekly Paclitaxel in Adult Patients With Advanced, Previously Treated Gastric and Gastro-Esophageal Junction Adenocarcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out whether it is better to receive a new drug, BBI608, in addition to paclitaxel chemotherapy or better to receive paclitaxel chemotherapy alone as second line treatment for gastric and gastroesophageal junction cancer after prior first line platinum and fluoropyrimidine based chemotherapy.
Study identification
- NCT ID
- NCT02178956
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 714 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Type not available)
- Primary completion
- Sep 20, 2017 (Actual)
- Completion
- Sep 20, 2017 (Actual)
- Last update posted
- Nov 15, 2023
2014 – 2017
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Arizona | Scottsdale | Arizona | 85259 | — |
| Colorado Cancer Research Program | Denver | Colorado | 80222 | — |
| Indiana University Health Goshen Center For Cancer Care | Goshen | Indiana | 46526 | — |
| Northern Indiana Cancer Research Consortium | South Bend | Indiana | 46628 | — |
| Siouxland Regional Cancer Center | Sioux City | Iowa | 51101 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Ochsner NCI CORP | New Orleans | Louisiana | 70121 | — |
| Spectrum Health Butterworth | Grand Rapids | Michigan | 49503 | — |
| Munson Medical Center | Traverse City | Michigan | 49684 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Metro-Minnesota NCI CORP | Saint Louis Park | Minnesota | 55416 | — |
| Heartland NCORP | St Louis | Missouri | 63131 | — |
| New Hampshire Oncology Hematology - Concord | Concord | New Hampshire | 03106 | — |
| New Hampshire Oncology Hematology - Laconia | Laconia | New Hampshire | 03246 | — |
| Weill Medical College of Cornell University | New York | New York | 10065 | — |
| State University of New York Upstate Medical University | Syracuse | New York | 13210 | — |
| Indiana University Health University Hospital | Chapel Hill | North Carolina | 27516 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| The University of Oklahoma Health Sciences Center (OUHSC) | Oklahoma City | Oklahoma | 73104 | — |
| Geisinger Medical Center | Danville | Pennsylvania | 17822 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Swedish Cancer Institute/ Swedish Health Services | Seattle | Washington | 98104 | — |
| Saint Vincent Hospital CCOP | Green Bay | Wisconsin | 54301 | — |
| St. Mary's Hospital | Green Bay | Wisconsin | 54307 | — |
| Gundersen Lutheran Medical Center | La Crosse | Wisconsin | 54601 | — |
| Marshfield CCOP | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 237 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02178956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02178956 live on ClinicalTrials.gov.